Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
FRISCO, Texas, Jan. 19, 2017 -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource (MDO) manufacturer, today announced that its subsidiary, Centro de Construccion de Cardioestimuladores del Uruguay S.A. (CCC), has signed a new supply agreement with Mainstay Medical Limited (MML), a subsidiary of Mainstay Medical International plc (Mainstay).
|
|||
The supply agreement becomes effective in January 2017 and replaces the engineering agreement that has been in place since 2010. Under the supply agreement, CCC will continue as the exclusive manufacturer of the implantable pulse generator and certain accompanying technology, including software, for MML’s ReActiv8® system. ReActiv8 is an implantable neurostimulation system used to treat disabling Chronic Low Back Pain (CLBP).
“Our agreement with Mainstay further demonstrates Integer’s growing position as a key service provider in the development and manufacturing of integrated systems within the active implantable market,” said Tony Gonzalez, president of Integer’s Cardiac Rhythm Management & Neuromodulation product category. “We are excited to extend our partnership with Mainstay and we look forward to our continued role in helping Mainstay bring ReActiv8 to market. Through their relationship with us, Mainstay is able to leverage our core technology and manufacturing footprint to more efficiently and cost-effectively bring the ReActiv8 system to patients suffering from CLBP.”
Peter Crosby, Mainstay’s CEO, said, “We are pleased to complete the new supply agreement with CCC as we advance our commercialization activities relating to ReActiv8.”
About Integer™
Integer Holdings Corporation (NYSE:ITGR) is one of the largest medical device outsource (MDO) manufacturers in the world serving the cardiac, neuromodulation, orthopedics, vascular, advanced surgical and portable medical markets. The company provides innovative, high-quality medical technologies that enhance the lives of patients worldwide. In addition, it develops batteries for high-end niche applications in energy, military, and environmental markets. The company's brands include GreatbatchTM Medical, Lake Region MedicalTM and ElectrochemTM. Additional information is available at www.integer.net.
Integer Contacts Investor Relations Amy Wakeham [email protected] 214.618.4978 Media Relations Jeannine Lee [email protected] 972.668.4593
